Literature DB >> 7457474

Pneumococcal bacteremia in Charleston County, South Carolina.

G A Filice, C P Darby, D W Fraser.   

Abstract

To describe the epidemiology of pneumococcal bacteremia in a large population, this study reviewed medical records for residents of Charleston County, South Carolina, who had pneumococci isolated from blood cultures during the period 1974-1976. The overall incidence of documented pneumococcal bacteremia was 8.5 cases per 100,000 population per year. It was highest for those in the first two years of life (35 per 100,000 per year) and those in their sixties (21 per 100,000 per year). The incidence was more than five times higher in blacks than in whites and within races appeared to be independent of socioeconomic status or population density. Seventy-three per cent of the cases occurred in persons with another medical problem. These data on the incidence of documented pneumococcal bacteremia underestimate the true incidence of bacteremia to the extent that blood cultures were not performed under optimal circumstances for all persons with compatible clinical syndromes. The data suggest that certain groups would benefit from vaccination against pneumococcal disease if the vaccines are shown to be safe and effective for these groups.

Entities:  

Mesh:

Year:  1980        PMID: 7457474     DOI: 10.1093/oxfordjournals.aje.a113055

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

Review 1.  Immunizations in the elderly.

Authors:  D W Bentley
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

2.  Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Authors:  M A Julie Westerink; Harry W Schroeder; Moon H Nahm
Journal:  Aging Dis       Date:  2011-07-20       Impact factor: 6.745

3.  Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status.

Authors:  A Z LaCroix; S Lipson; T P Miles; L White
Journal:  Public Health Rep       Date:  1989 Jul-Aug       Impact factor: 2.792

4.  The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.

Authors:  Nancy F Crum-Cianflone; Mollie Roediger; Kathy Huppler Hullsiek; Anuradha Ganesan; Michael Landrum; Amy Weintrob; Brian Agan; Sheila Medina; Jeremy Rahkola; Braden Hale; Edward N Janoff
Journal:  Vaccine       Date:  2010-09-29       Impact factor: 3.641

5.  Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.

Authors:  Linda G Jones; Yan Zhang; Mustafa I Ahmed; O James Ekundayo; Shamima Akhter; Patricia Sawyer; Inmaculada Aban; Richard V Sims; Ali Ahmed
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

Review 6.  Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.

Authors:  Kuan-Yeh Lee; Mao-Song Tsai; Kuang-Che Kuo; Jen-Chih Tsai; Hsin-Yun Sun; Aristine C Cheng; Sui-Yuan Chang; Chen-Hsiang Lee; Chien-Ching Hung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.

Authors:  J A Leech; A Gervais; F L Ruben
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

8.  Pneumococcal vaccination in a remote population of high-risk Alaska Natives.

Authors:  M Davidson; C Chamblee; H G Campbell; L R Bulkow; G E Taylor; A P Lanier; J Berner; J S Spika; W W Williams; J P Middaugh
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

9.  Risk factors for septicemia-associated mortality in older adults.

Authors:  M E Salive; R B Wallace; A M Ostfeld; S Satterfield; R J Havlik
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

10.  Pneumococcal bacteremia in Monroe County, New York.

Authors:  N M Bennett; J Buffington; F M LaForce
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.